Yarlagadda S. Babu
2017
In 2017, Yarlagadda S. Babu earned a total compensation of $1.6M as Senior Vice President of Drug Discovery at BioCryst Pharmaceuticals, a 145% increase compared to previous year.
Compensation breakdown
| Bonus | $126,872 |
|---|---|
| Non-Equity Incentive Plan | $115,304 |
| Option Awards | $1,001,288 |
| Salary | $382,480 |
| Other | $13,500 |
| Total | $1,639,444 |
Babu received $1M in option awards, accounting for 61% of the total pay in 2017.
Babu also received $126.9K in bonus, $115.3K in non-equity incentive plan, $382.5K in salary and $13.5K in other compensation.
Rankings
In 2017, Yarlagadda S. Babu's compensation ranked 6,525th out of 14,666 executives tracked by ExecPay. In other words, Babu earned more than 55.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,525 out of 14,666 | 56th |
Division Manufacturing | 2,410 out of 5,772 | 58th |
Major group Chemicals And Allied Products | 776 out of 2,075 | 63rd |
Industry group Drugs | 599 out of 1,731 | 65th |
Industry Biological Products, Except Diagnostic Substances | 108 out of 313 | 66th |
Source: SEC filing on May 10, 2018.
Babu's colleagues
We found four more compensation records of executives who worked with Yarlagadda S. Babu at BioCryst Pharmaceuticals in 2017.
2017
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
2017
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
2017
Thomas Staab
BioCryst Pharmaceuticals
Chief Financial Officer
2017
Lynne Powell
BioCryst Pharmaceuticals